Cargando…

Activation of AKT/mammalian target of rapamycin signaling in the peripheral blood of women with premature ovarian insufficiency and its correlation with FMR1 expression

BACKGROUND: The protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway regulates early follicular activation and follicular pool maintenance in female germline cells. Fragile X mental retardation 1 (FMR1) regulates folliculogenesis and it is variably expressed in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rehnitz, Julia, Messmer, Birgitta, Bender, Ulrike, Nguyen, Xuan Phuoc, Germeyer, Ariane, Hinderhofer, Katrin, Strowitzki, Thomas, Capp, Edison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898473/ https://www.ncbi.nlm.nih.gov/pubmed/35248053 http://dx.doi.org/10.1186/s12958-022-00919-0

Ejemplares similares

FMR1 and AKT/mTOR Signaling in Human Granulosa Cells: Functional Interaction and Impact on Ovarian Response
por: Rehnitz, Julia, et al.
Publicado: (2021)

FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
por: Rehnitz, Julia, et al.
Publicado: (2018)

Expression of FMRpolyG in Peripheral Blood Mononuclear Cells of Women with Fragile X Mental Retardation 1 Gene Premutation
por: Nguyen, Xuan Phuoc, et al.
Publicado: (2022)

Factors Influencing Success Rate of Intracytoplasmic Sperm Injection with Azoospermic Male Patients
por: Rehnitz, Julia, et al.
Publicado: (2020)

Premature recruitment of oocyte pool and increased mTOR activity in Fmr1 knockout mice and reversal of phenotype with rapamycin
por: Mok-Lin, E., et al.
Publicado: (2018)

Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency
por: Wheeler, Anne C., et al.
Publicado: (2014)

The significance of FMR1 CGG repeats in Chinese women with premature ovarian insufficiency and diminished ovarian reserve
por: Tang, Ruiyi, et al.
Publicado: (2020)

Distribution of FMR1 and FMR2 Repeats in Argentinean Patients with Primary Ovarian Insufficiency
por: Espeche, Lucía Daniela, et al.
Publicado: (2017)

Decreased Autophagy Impairs Decidualization of Human Endometrial Stromal Cells: A Role for ATG Proteins in Endometrial Physiology
por: Mestre Citrinovitz, Ana Cecilia, et al.
Publicado: (2019)

Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps
por: Xu, Geng, et al.
Publicado: (2009)

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
por: Alvarez-Mora, Maria Isabel, et al.
Publicado: (2022)

Cytokines in relation to hCG are significantly altered in asymptomatic women with miscarriage – a pilot study
por: Freis, Alexander, et al.
Publicado: (2018)

Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells
por: Lange, Carsten, et al.
Publicado: (2023)

Study of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 Gene
por: Barasoain, Maitane, et al.
Publicado: (2016)

Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line
por: Lange, Carsten, et al.
Publicado: (2021)

Patient- and cycle-specific factors affecting the outcome of frozen–thawed embryo transfers
por: Holschbach, Verena, et al.
Publicado: (2023)

Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures - a pilot study
por: Germeyer, Ariane, et al.
Publicado: (2010)

GRN, NOTCH3, FN1, and PINK1 expression in eutopic endometrium – potential biomarkers in the detection of endometriosis – a pilot study
por: Holzer, Isabell, et al.
Publicado: (2020)

Tremor-Ataxia syndrome and primary ovarian insufficiency in anFMR1 premutation carrier
por: Saldarriaga-Gil, Wilmar, et al.
Publicado: (2017)

FMR1 Premutation Is an Uncommon Explanation for Premature Ovarian Failure in Han Chinese
por: Guo, Ting, et al.
Publicado: (2014)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Predictors for the Early Termination of a Psychological Intervention During Treatment with Assisted Reproductive Technologies
por: Bernd, Marie, et al.
Publicado: (2020)

Intraindividual Embryo Morphokinetics Are Not Affected by a Switch of the Ovarian Stimulation Protocol Between GnRH Agonist vs. Antagonist Regimens in Consecutive Cycles
por: Dietrich, Jens E., et al.
Publicado: (2020)

Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain‐of‐function toxicity mechanism contributing to the pathogenesis of fragile X‐associated premature ovarian insufficiency
por: Rosario, Roseanne, et al.
Publicado: (2022)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
por: Martelli, Alberto M., et al.
Publicado: (2010)

Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade
por: Rivera Rivera, Amilcar, et al.
Publicado: (2016)

Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling
por: Liu, Jing, et al.
Publicado: (2021)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency
por: Murray, Anna, et al.
Publicado: (2014)

Refining the risk for fragile X–associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size
por: Allen, Emily Graves, et al.
Publicado: (2021)

Premature ovarian insufficiency: Pathogenesis and management
por: Fenton, Anna J.
Publicado: (2015)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pcaj7bhe3irqdjijgtroe9kv5a